skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effect of phorbol and Bryostatin I on chondrogenic expression of chick limb bud, in vitro

Journal Article · · Life Sci.; (United States)

The present paper describes the effects of PMA (phorbol 12-myristate 13 acetate) on in vitro chondrogenesis in non-passaged, embryonic limb bud cells, relative to the effects of Bryostatin I. This compound also activates C kinase and binds competitively to the phorbol ester receptor, yet does not affect cell differentiation. Levels of PMA as low as 10/sup -7/ M markedly reduced cartilage formation in 4-day cultures, as indicated by nodule count and Alcian blue staining for chondroitin sulfate. Coadministration of Bryostatin I at equimolar concentration prevented the PMA inhibitory effect on chondrocytic expression. This confirms other findings that phorbol activation of C kinase cannot exclusively account for the activity of phorbol on cell expression. Altering the time of PMA exposure demonstrated that PMA inhibited chondrocyte phenotypic expression, rather than cell commitment: early exposure to PMA had little inhibitor effect on the staining index, whereas, exposure from 49-96 h and 0-96 h had moderate and strong inhibitory effects, respectively, on cartilage synthesis. Further research on the phorbol/Bryostatin I interaction should add to their knowledge of the control processes involved in tumor promotion and cell differentiation. 21 references, 3 figures.

Research Organization:
Univ. of Kansas Medical Center, Kansas City
OSTI ID:
6062388
Journal Information:
Life Sci.; (United States), Vol. 41:17
Country of Publication:
United States
Language:
English